District / regional hospital EML comments requested CV, neuro and psychiatry 8 May

The NDoH Essential Medicines Programme request comments on the the 3 chapters of the hospital level standard treatment guidelines (STG) essential medicines list (EML). Click here to view drafts

  • Chapter 3: Cardiovascular conditions
  • Chapter 14: Neurological conditions
  • Chapter 15: Psychiatry conditions

Reviewed by: the National EML Committee (appointed by the Minister)
Version reviewed: STG and EML Hospital Level, Adults (2012 edition)
Target users: doctors and nurses providing care at district and regional hospitals to provide access to pharmaceuticals to manage common conditions.
Aim of comment: to identify of gross errors, particularly diagnosis and treatment. Completion of a short motivation to substantiate any comment made is recommendations made.
Where an alternative medicine is recommended, this should be supported by appropriate evidence.
See updated guideline for the Motivation of a New Medicine on the National EML.
Comment by8 May 2015

Submit comments to: Trudy Leong,  Tel: 012 395 8287 Fax to e-mail: 0862484875 E-mail: [email protected]

District / regional hospital EML comments requested CV, neuro and psychiatry 8 May

The NDoH Essential Medicines Programme request comments on the the 3 chapters of the hospital level standard treatment guidelines (STG) essential medicines list (EML). Click here to view drafts

  • Chapter 3: Cardiovascular conditions
  • Chapter 14: Neurological conditions
  • Chapter 15: Psychiatry conditions

Reviewed by: the National EML Committee (appointed by the Minister)
Version reviewed: STG and EML Hospital Level, Adults (2012 edition)
Target users: doctors and nurses providing care at district and regional hospitals to provide access to pharmaceuticals to manage common conditions.
Aim of comment: to identify of gross errors, particularly diagnosis and treatment. Completion of a short motivation to substantiate any comment made is recommendations made.
Where an alternative medicine is recommended, this should be supported by appropriate evidence.
See updated guideline for the Motivation of a New Medicine on the National EML.
Comment by8 May 2015

Submit comments to: Trudy Leong,  Tel: 012 395 8287 Fax to e-mail: 0862484875 E-mail: [email protected]